OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Andreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 1, pp. 95-106
Open Access | Times Cited: 90
Andreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 1, pp. 95-106
Open Access | Times Cited: 90
Showing 1-25 of 90 citing articles:
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 1, pp. 3-18
Open Access | Times Cited: 1015
Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 1, pp. 3-18
Open Access | Times Cited: 1015
Rheumatoid arthritis
Andrea Di Matteo, Joan M. Bathon, Paul Emery
The Lancet (2023) Vol. 402, Iss. 10416, pp. 2019-2033
Closed Access | Times Cited: 203
Andrea Di Matteo, Joan M. Bathon, Paul Emery
The Lancet (2023) Vol. 402, Iss. 10416, pp. 2019-2033
Closed Access | Times Cited: 203
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
Thomas Frisell, Hannah Bower, Matilda Morin, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 5, pp. 601-610
Open Access | Times Cited: 47
Thomas Frisell, Hannah Bower, Matilda Morin, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 5, pp. 601-610
Open Access | Times Cited: 47
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story
Michael Bonelli, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 2, pp. 139-160
Open Access | Times Cited: 45
Michael Bonelli, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 2, pp. 139-160
Open Access | Times Cited: 45
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician
Zoltán Szekanecz, Maya H Buch, Christina Charles‐Schoeman, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 101-115
Closed Access | Times Cited: 45
Zoltán Szekanecz, Maya H Buch, Christina Charles‐Schoeman, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 101-115
Closed Access | Times Cited: 45
Update on the pathophysiology and treatment of primary Sjögren syndrome
Chiara Baldini, Giovanni Fulvio, Gaetano La Rocca, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 8, pp. 473-491
Closed Access | Times Cited: 17
Chiara Baldini, Giovanni Fulvio, Gaetano La Rocca, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 8, pp. 473-491
Closed Access | Times Cited: 17
Genistein alleviates rheumatoid arthritis by inhibiting fibroblast-like synovial exosome secretion regulated by the Rab27/nSMase2/Mfge8 pathway
Jiajia Liu, Jinyang Shi, Shuling Niu, et al.
Food & Function (2025)
Open Access | Times Cited: 1
Jiajia Liu, Jinyang Shi, Shuling Niu, et al.
Food & Function (2025)
Open Access | Times Cited: 1
Pioneering a paradigm shift in asthma management: remission as a treatment goal
Marek Lommatzsch, Roland Buhl, Giorgio Walter Canonica, et al.
The Lancet Respiratory Medicine (2023) Vol. 12, Iss. 2, pp. 96-99
Closed Access | Times Cited: 36
Marek Lommatzsch, Roland Buhl, Giorgio Walter Canonica, et al.
The Lancet Respiratory Medicine (2023) Vol. 12, Iss. 2, pp. 96-99
Closed Access | Times Cited: 36
Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study
Ho So, Tommy Lam, Huan Meng, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 11, pp. 1387-1393
Open Access | Times Cited: 27
Ho So, Tommy Lam, Huan Meng, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 11, pp. 1387-1393
Open Access | Times Cited: 27
The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review
Po‐Ku Chen, Kuo‐Tung Tang, Der‐Yuan Chen
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 626-626
Open Access | Times Cited: 8
Po‐Ku Chen, Kuo‐Tung Tang, Der‐Yuan Chen
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 626-626
Open Access | Times Cited: 8
The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases
Minjun Wang, Hailing Zhang, Fei Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Minjun Wang, Hailing Zhang, Fei Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases
Liuting Zeng, Kailin Yang, Ganpeng Yu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 7
Liuting Zeng, Kailin Yang, Ganpeng Yu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 7
Remission in asthma
Marek Lommatzsch
Current Opinion in Pulmonary Medicine (2024) Vol. 30, Iss. 3, pp. 325-329
Open Access | Times Cited: 6
Marek Lommatzsch
Current Opinion in Pulmonary Medicine (2024) Vol. 30, Iss. 3, pp. 325-329
Open Access | Times Cited: 6
Therapeutic Potential of Plant-Derived Compounds and Plant Extracts in Rheumatoid Arthritis—Comprehensive Review
Mateusz Kciuk, Anjali Garg, Manni Rohilla, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 775-775
Open Access | Times Cited: 6
Mateusz Kciuk, Anjali Garg, Manni Rohilla, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 775-775
Open Access | Times Cited: 6
Fibroblast-like synoviocytes-derived exosomal circFTO deteriorates rheumatoid arthritis by enhancing N6-methyladenosine modification of SOX9 in chondrocytes
Guoqing Li, Yuxuan Fang, Nan Xu, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Guoqing Li, Yuxuan Fang, Nan Xu, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis
Khaldoun Chaabo, Estee Chan, Toby Garrood, et al.
RMD Open (2024) Vol. 10, Iss. 1, pp. e003784-e003784
Open Access | Times Cited: 5
Khaldoun Chaabo, Estee Chan, Toby Garrood, et al.
RMD Open (2024) Vol. 10, Iss. 1, pp. e003784-e003784
Open Access | Times Cited: 5
Fengshi Gutong Capsules Attenuates Cia-Induced Ra Bone Destruction in Rats by Targeting Tnf-Α Inhibition: Integration and Experimental Validation of Network Pharmacology and Proteomics
Jiahui Liu, Sheng Zhang, Biao Qu, et al.
(2025)
Closed Access
Jiahui Liu, Sheng Zhang, Biao Qu, et al.
(2025)
Closed Access
Medication adherence in rheumatoid arthritis: implications for cardiovascular disease risk and strategies to address in U.S. Veterans
Isaac D. Smith, Bryant R. England, Neha J. Pagidipati, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2025)
Closed Access
Isaac D. Smith, Bryant R. England, Neha J. Pagidipati, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2025)
Closed Access
Machine learning-based prediction model integrating ultrasound scores and clinical features for the progression to rheumatoid arthritis in patients with undifferentiated arthritis
Xiaoli Hu, Xianmei Liu, Yuan Xu, et al.
Clinical Rheumatology (2025)
Closed Access
Xiaoli Hu, Xianmei Liu, Yuan Xu, et al.
Clinical Rheumatology (2025)
Closed Access
Refining insights into rheumatoid arthritis-associated liver dysfunction: Opportunities for methodological advancements and clinical implications
Z. X. Liu, Peng Guo, Guohong Xiang, et al.
European Journal of Internal Medicine (2025)
Closed Access
Z. X. Liu, Peng Guo, Guohong Xiang, et al.
European Journal of Internal Medicine (2025)
Closed Access
Remote-Customized Telecontrol for Patients with Rheumatoid Arthritis: The iARPlus (Innovative Approach in Rheumatology) Initiative
Fausto Salaffi, Sonia Farah, Eleonora Di Donato, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 1, pp. 30-30
Open Access
Fausto Salaffi, Sonia Farah, Eleonora Di Donato, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 1, pp. 30-30
Open Access
Regulatory role of DBC1 in inflammation and autoimmune diseases
Jinzhi Wu, Fan Yang, Guanhua Xu, et al.
Rheumatology & autoimmunity (2025)
Open Access
Jinzhi Wu, Fan Yang, Guanhua Xu, et al.
Rheumatology & autoimmunity (2025)
Open Access
Chinese Registry of Rheumatoid Arthritis (CREDIT) VI: Temporal Trends in Patients With Early Rheumatoid Arthritis and Moderate‐To‐Severe Disease Activity ‐ A Multicenter Cohort Study of Treatment Strategies and Outcomes
Yafang Deng, Qiao Lin, Hongbin Li, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access
Yafang Deng, Qiao Lin, Hongbin Li, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access
Effectively alleviate rheumatoid arthritis via maintaining redox balance, inducing macrophage repolarization and restoring homeostasis of fibroblast-like synoviocytes by metformin-derived carbon dots
Rui Zhang, Xingyu Lin, Rongjie Lin, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Rui Zhang, Xingyu Lin, Rongjie Lin, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre study
Caterina Baldi, Stefano Gentileschi, Francesca Li Gobbi, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Caterina Baldi, Stefano Gentileschi, Francesca Li Gobbi, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
